Advances in the therapy of Alzheimer’s disease: targeting amyloid beta and tau and perspectives for the future
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in the therapy of Alzheimer’s disease: targeting amyloid beta and tau and perspectives for the future
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume 15, Issue 1, Pages 83-105
Publisher
Informa UK Limited
Online
2014-12-24
DOI
10.1586/14737175.2015.995637
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vivo tau imaging: Obstacles and progress
- (2014) Victor L. Villemagne et al. Alzheimers & Dementia
- Rethinking the Food and Drug Administration's 2013 guidance on developing drugs for early-stage Alzheimer's disease
- (2014) Lon S. Schneider Alzheimers & Dementia
- Florbetapir (18F) for brain amyloid positron emission tomography: Highlights on the European marketing approval
- (2014) Anabel Cortes-Blanco et al. Alzheimers & Dementia
- Alzheimer's disease research and development: a call for a new research roadmap
- (2014) Howard H. Feldman et al. Annals of the New York Academy of Sciences
- Apolipoprotein E in Alzheimer's Disease: An Update
- (2014) Jin-Tai Yu et al. Annual Review of Neuroscience
- Alzheimer’s disease from researcher to caregiver: a personal journey and call to action
- (2014) Diane Stephenson Expert Review of Neurotherapeutics
- Harmonized diagnostic criteria for Alzheimer's disease: recommendations
- (2014) J. C. Morris et al. JOURNAL OF INTERNAL MEDICINE
- Advances in the prevention of Alzheimer's disease and dementia
- (2014) A. Solomon et al. JOURNAL OF INTERNAL MEDICINE
- Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014
- (2014) L. S. Schneider et al. JOURNAL OF INTERNAL MEDICINE
- Suppression of Alzheimer-Associated Inflammation by Microglial Prostaglandin-E2 EP4 Receptor Signaling
- (2014) N. S. Woodling et al. JOURNAL OF NEUROSCIENCE
- A population perspective on the IWG-2 research diagnostic criteria for Alzheimer's disease
- (2014) Carol Brayne LANCET NEUROLOGY
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- The A4 Study: Stopping AD Before Symptoms Begin?
- (2014) R. A. Sperling et al. Science Translational Medicine
- The Preclinical Alzheimer Cognitive Composite
- (2014) Michael C. Donohue et al. JAMA Neurology
- CSF biomarker variability in the Alzheimer's Association quality control program
- (2013) Niklas Mattsson et al. Alzheimers & Dementia
- Designing drug trials for Alzheimer’s disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force
- (2013) Bruno Vellas et al. Alzheimers & Dementia
- The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): Study design and progress
- (2013) Miia Kivipelto et al. Alzheimers & Dementia
- CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease
- (2013) Simone Lista et al. Alzheimers & Dementia
- Tau-aggregation inhibitor therapy for Alzheimer's disease
- (2013) Claude M. Wischik et al. BIOCHEMICAL PHARMACOLOGY
- Immunotherapy in Alzheimer’s Disease: Do We Have All the Pieces of the Puzzle?
- (2013) Marie Sarazin et al. BIOLOGICAL PSYCHIATRY
- Molecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain Tissue
- (2013) Jun-Xia Lu et al. CELL
- Between new genetic discoveries and large randomized trials—neurological research in the era of systems medicine
- (2013) Thomas Misgeld et al. EMBO REPORTS
- Regulatable transgenic mouse models of Alzheimer disease: onset, reversibility and spreading of Tau pathology
- (2013) Katja Hochgräfe et al. FEBS Journal
- A concise radiosynthesis of the tau radiopharmaceutical, [18F]T807
- (2013) Timothy M. Shoup et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- Passive immunotherapy for Alzheimer’s disease: What have we learned, and where are we headed?
- (2013) P. S. Aisen et al. Journal of Nutrition Health & Aging
- Immunotherapy against amyloid pathology in Alzheimer's disease
- (2013) Daniela Galimberti et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II
- (2013) Fiona E Matthews et al. LANCET
- Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
- (2013) Stephanie JB Vos et al. LANCET NEUROLOGY
- Moving towards early clinical trials for amyloid-targeted therapy in Alzheimer's disease
- (2013) Paul S. Aisen et al. NATURE REVIEWS DRUG DISCOVERY
- Alzheimer disease therapy—moving from amyloid-β to tau
- (2013) Ezio Giacobini et al. Nature Reviews Neurology
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
- (2013) Chia-Chen Liu et al. Nature Reviews Neurology
- Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later
- (2013) C. M. Roe et al. NEUROLOGY
- Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden
- (2013) C. Qiu et al. NEUROLOGY
- Regulatory Innovation and Drug Development for Early-Stage Alzheimer's Disease
- (2013) Nicholas Kozauer et al. NEW ENGLAND JOURNAL OF MEDICINE
- New Insights into the Dementia Epidemic
- (2013) Eric B. Larson et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
- (2013) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study
- (2013) Edo Richard et al. BMJ Open
- Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease
- (2013) Rik Vandenberghe et al. NeuroImage-Clinical
- Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease
- (2013) Gaël Chételat et al. NeuroImage-Clinical
- The A4 trial: Anti-amyloid treatment of asymptomatic Alzheimer's disease
- (2012) Reisa Sperling et al. Alzheimers & Dementia
- Safety and biomarker effects of solanezumab in patients with Alzheimer’s disease
- (2012) Martin Farlow et al. Alzheimers & Dementia
- Development of biomarkers to chart all Alzheimer’s disease stages: The royal road to cutting the therapeutic Gordian Knot
- (2012) Harald Hampel et al. Alzheimers & Dementia
- Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementia
- (2012) Anna H. Noel-Storr et al. Alzheimers & Dementia
- Targeting Phospho-Ser422 by Active Tau Immunotherapy in the THYTau22 Mouse Model: A Suitable Therapeutic Approach
- (2012) Nadege Zommer et al. Current Alzheimer Research
- Therapeutic strategies for tau mediated neurodegeneration
- (2012) Y. Yoshiyama et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Recruitment strategies for preventive trials. The MAPT study (Multidomain Alzheimer Preventive Trial)
- (2012) I. Carrie et al. Journal of Nutrition Health & Aging
- Genetic insights in Alzheimer's disease
- (2012) Karolien Bettens et al. LANCET NEUROLOGY
- Targeting Synaptic Dysfunction in Alzheimer’s Disease Therapy
- (2012) Robert Nisticò et al. MOLECULAR NEUROBIOLOGY
- A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
- (2012) Thorlakur Jonsson et al. NATURE
- Down's syndrome and Alzheimer's disease: towards secondary prevention
- (2012) Seth Ness et al. NATURE REVIEWS DRUG DISCOVERY
- Alzheimer's disease market: hope deferred
- (2012) Zelicia Gerald et al. NATURE REVIEWS DRUG DISCOVERY
- Preclinical Alzheimer disease—the challenges ahead
- (2012) Reisa A. Sperling et al. Nature Reviews Neurology
- From inherited to sporadic AD—crossing the biomarker bridge
- (2012) Harald Hampel et al. Nature Reviews Neurology
- Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study
- (2012) E. M. C. Schrijvers et al. NEUROLOGY
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dementia prevention: current epidemiological evidence and future perspective
- (2012) Francesca Mangialasche et al. Alzheimers Research & Therapy
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Chronic Divalproex Sodium to Attenuate Agitation and Clinical Progression of Alzheimer Disease
- (2011) Pierre N. Tariot ARCHIVES OF GENERAL PSYCHIATRY
- Risk Factors and Preventive Interventions for Alzheimer Disease
- (2011) Martha L. Daviglus ARCHIVES OF NEUROLOGY
- Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models
- (2011) Xiyun Chai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ‘Clinical trials in Alzheimer’s disease’: immunotherapy approaches
- (2011) Julien Delrieu et al. JOURNAL OF NEUROCHEMISTRY
- Progress in the development of new drugs in Alzheimer’s disease
- (2011) Antoine Piau et al. Journal of Nutrition Health & Aging
- The projected effect of risk factor reduction on Alzheimer's disease prevalence
- (2011) Deborah E Barnes et al. LANCET NEUROLOGY
- Chronic divalproex sodium use and brain atrophy in Alzheimer disease
- (2011) A. S. Fleisher et al. NEUROLOGY
- Anti-Aβ Therapeutics in Alzheimer's Disease: The Need for a Paradigm Shift
- (2011) Todd E. Golde et al. NEURON
- Tau-Targeted Immunization Impedes Progression of Neurofibrillary Histopathology in Aged P301L Tau Transgenic Mice
- (2011) Mian Bi et al. PLoS One
- Testing the Right Target and Right Drug at the Right Stage
- (2011) R. A. Sperling et al. Science Translational Medicine
- Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia
- (2011) Michael Ewers et al. TRENDS IN NEUROSCIENCES
- Tau transgenic rat model and response to tau vaccine
- (2010) Michal Novak Alzheimers & Dementia
- Safety and Changes in Plasma and Cerebrospinal Fluid Amyloid β After a Single Administration of an Amyloid β Monoclonal Antibody in Subjects With Alzheimer Disease
- (2010) Eric R. Siemers et al. CLINICAL NEUROPHARMACOLOGY
- Revising the definition of Alzheimer's disease: a new lexicon
- (2010) Bruno Dubois et al. LANCET NEUROLOGY
- Alzheimer's disease: clinical trials and drug development
- (2010) Francesca Mangialasche et al. LANCET NEUROLOGY
- Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
- (2010) Harald Hampel et al. NATURE REVIEWS DRUG DISCOVERY
- Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease
- (2010) Lars M. Ittner et al. NATURE REVIEWS NEUROSCIENCE
- Nature versus Nurture: Death of a Dogma, and the Road Ahead
- (2010) Bryan J. Traynor et al. NEURON
- The Genetics of Alzheimer Disease: Back to the Future
- (2010) Lars Bertram et al. NEURON
- Prevention of Dementia by Intensive Vascular Care (PreDIVA)
- (2009) Edo Richard et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Identification, characterization, and comparison of amino-terminally truncated Aβ 42 peptides in Alzheimer's disease brain tissue and in plasma from Alzheimer's patients receiving solanezumab immunotherapy treatment
- (2009) Ronald B. DeMattos et al. Alzheimers & Dementia
- Tau vaccine: Active immunization with misfolded tau protein attenuates tau pathology in the transgenic rat model of tauopathy
- (2009) Michal Novak Alzheimers & Dementia
- Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” The Multidomain Alzheimer Preventive Trial (MAPT): A new approach to the prevention of Alzheimer's disease
- (2009) Sophie Gillette-Guyonnet et al. Alzheimers & Dementia
- Methylene blue and Alzheimer's disease
- (2009) Murat Oz et al. BIOCHEMICAL PHARMACOLOGY
- Secretase inhibitors and modulators for Alzheimer’s disease treatment
- (2009) Taisuke Tomita Expert Review of Neurotherapeutics
- Lithium Trial in Alzheimer's Disease
- (2009) Harald Hampel et al. JOURNAL OF CLINICAL PSYCHIATRY
- Challenges in the conduct of disease-modifying trials in ad: Practical experience from a phase 2 trial of TAU-aggregation inhibitor therapy
- (2009) C. Wischik et al. Journal of Nutrition Health & Aging
- Effect of tramiprosate in patients with mild-to-moderate alzheimer’s disease: Exploratory analyses of the MRI sub-group of the alphase study
- (2009) S. Gauthier et al. Journal of Nutrition Health & Aging
- A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
- (2009) S. Salloway et al. NEUROLOGY
- Trends in the prevalence and mortality of cognitive impairment in the United States: Is there evidence of a compression of cognitive morbidity?
- (2008) Kenneth M. Langa et al. Alzheimers & Dementia
- A feasibility and tolerability study of lithium in Alzheimer's disease
- (2008) Alastair Macdonald et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Immunotherapy Reduces Vascular Amyloid- in PDAPP Mice
- (2008) S. Schroeter et al. JOURNAL OF NEUROSCIENCE
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now